InMed Announces Independent Shareholder Approval and Completes Share Consolidation
InMed Pharmaceuticals Inc. has obtained shareholder approval for a corporate name change to Mentari Therapeutics, Inc., and completed a share consolidation 1:10 effective November 5, 2026, with its NASDAQ: INM shares continuing to trade.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed